Evidence map›Paper›PMID 35169606›Full record

ArticleGynecologic oncology reports2022

Iliac artery-enteric fistula developed during bevacizumab-containing chemotherapy for recurrent cervical cancer: A case report and literature review.

Yuki Karasawa, Seiji Mabuchi, Yuri Matsumoto, Masahiko Umemoto, Ayako Miyazaki, Ayako Watanabe, Ryoko Okura, Risa Atsumi, Kosuke Sakurai, Takashi Shibuya and 1 more

Abstract readCase Reports
In one paragraph

Article in Gynecologic oncology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuki KarasawaDepartment of Obstetrics and Gynecology, Suita Tokushukai Hospital, 21-1 Senriokanishi, Suita, Osaka 565-0814, Japan.
Seiji MabuchiDepartment of Gynecology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka-shi, Osaka 541-8567, Japan.
Yuri MatsumotoDepartment of Obstetrics and Gynecology, Suita Tokushukai Hospital, 21-1 Senriokanishi, Suita, Osaka 565-0814, Japan.
Masahiko UmemotoDepartment of Obstetrics and Gynecology, Suita Tokushukai Hospital, 21-1 Senriokanishi, Suita, Osaka 565-0814, Japan.
Ayako MiyazakiDepartment of Obstetrics and Gynecology, Suita Tokushukai Hospital, 21-1 Senriokanishi, Suita, Osaka 565-0814, Japan.
Ayako WatanabeDepartment of Obstetrics and Gynecology, Suita Tokushukai Hospital, 21-1 Senriokanishi, Suita, Osaka 565-0814, Japan.
Ryoko OkuraDepartment of Obstetrics and Gynecology, Suita Tokushukai Hospital, 21-1 Senriokanishi, Suita, Osaka 565-0814, Japan.
Risa AtsumiDepartment of Obstetrics and Gynecology, Suita Tokushukai Hospital, 21-1 Senriokanishi, Suita, Osaka 565-0814, Japan.
Kosuke SakuraiDepartment of Radiology, Suita Tokushukai Hospital, 21-1 Senriokanishi, Suita, Osaka 565-0814, Japan.
Takashi ShibuyaDepartment of Cardiovascular Surgery, Suita Tokushukai Hospital, 21-1 Senriokanishi, Suita, Osaka 565-0814, Japan.
Fuminori KitadaDepartment of Obstetrics and Gynecology, Suita Tokushukai Hospital, 21-1 Senriokanishi, Suita, Osaka 565-0814, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An arterioenteric fistula is a devastating and life-threatening condition. As patients often present in extremis from hemorrhage shock, an early diagnosis and prompt life-saving interventions have to be performed. In this report, we describe a case of a 38-year-old Japanese woman who presented with hematochezia that rapidly progressed to hemorrhagic shock secondary to an iliac artery-enteric fistula that developed during bevacizumab-containing chemotherapy for recurrent cervical cancer. The patient underwent successful endovascular treatment with a covered stent-graft as a bridge to definitive open surgery.

Indexed as

BevacizumabCovered stentIliac artery-enteric fistulaRecurrent cervical cancer

Identifiers

PMID35169606
PMCPMC8829561

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.